Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 4
2021 18
2022 16
2023 19
2024 23
2025 28
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial.
Provenzano M, Puchades MJ, Garofalo C, Jongs N, D'Marco L, Andreucci M, De Nicola L, Gorriz JL, Heerspink HJL; ROTATE-3 study group; ROTATE-3 study group members. Provenzano M, et al. J Am Soc Nephrol. 2022 Aug;33(8):1569-1580. doi: 10.1681/ASN.2022020207. Epub 2022 Apr 19. J Am Soc Nephrol. 2022. PMID: 35440501 Free PMC article. Clinical Trial.
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options.
Galiero R, Caturano A, Vetrano E, Beccia D, Brin C, Alfano M, Di Salvo J, Epifani R, Piacevole A, Tagliaferri G, Rocco M, Iadicicco I, Docimo G, Rinaldi L, Sardu C, Salvatore T, Marfella R, Sasso FC. Galiero R, et al. Among authors: caturano a. Int J Mol Sci. 2023 Feb 10;24(4):3554. doi: 10.3390/ijms24043554. Int J Mol Sci. 2023. PMID: 36834971 Free PMC article. Review.
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors.
Salvatore T, Galiero R, Caturano A, Rinaldi L, Di Martino A, Albanese G, Di Salvo J, Epifani R, Marfella R, Docimo G, Lettieri M, Sardu C, Sasso FC. Salvatore T, et al. Among authors: caturano a. Int J Mol Sci. 2022 Mar 26;23(7):3651. doi: 10.3390/ijms23073651. Int J Mol Sci. 2022. PMID: 35409011 Free PMC article. Review.
Sarcopenic obesity and weight loss-induced muscle mass loss.
Caturano A, Amaro A, Berra CC, Conte C. Caturano A, et al. Curr Opin Clin Nutr Metab Care. 2025 Jul 1;28(4):339-350. doi: 10.1097/MCO.0000000000001131. Epub 2025 Apr 29. Curr Opin Clin Nutr Metab Care. 2025. PMID: 40296814 Free PMC article. Review.
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.
Zhang H, Targher G, Byrne CD, Kim SU, Wong VW, Valenti L, Glickman M, Ponce J, Mantzoros CS, Crespo J, Gronbaek H, Yang W, Eslam M, Wong RJ, Machado MV, Yu ML, Ghanem OM, Okanoue T, Liu JF, Lee YH, Xu XY, Pan Q, Sui M, Lonardo A, Yilmaz Y, Zhu LY, Moreno C, Miele L, Lupsor-Platon M, Zhao L, LaMasters TL, Gish RG, Zhang H, Nedelcu M, Chan WK, Xia MF, Bril F, Shi JP, Datz C, Romeo S, Sun J, Liu D, Sookoian S, Mao YM, Méndez-Sánchez N, Wang XY, Pyrsopoulos NT, Fan JG, Fouad Y, Sun DQ, Giannini C, Chai J, Xia ZF, Jun DW, Li GJ, Treeprasertsuk S, Li YX, Cheung TT, Zhang F, Goh GB, Furuhashi M, Seto WK, Huang H, Di Sessa A, Li QH, Cholongitas E, Zhang L, Silveira TR, Sebastiani G, Adams LA, Chen W, Qi X, Rankovic I, De Ledinghen V, Lv WJ, Hamaguchi M, Kassir R, Müller-Wieland D, Romero-Gomez M, Xu Y, Xu YC, Chen SY, Kermansaravi M, Kuchay MS, Lefere S, Parmar C, Lip GYH, Liu CJ, Åberg F, Lau G, George J, Sarin SK, Zhou JY, Zheng MH; MAFLD ICD-11 coding collaborators. Zhang H, et al. Hepatol Int. 2024 Aug;18(4):1178-1201. doi: 10.1007/s12072-024-10702-5. Epub 2024 Jun 15. Hepatol Int. 2024. PMID: 38878111
Post-fracture thromboprophylaxis: is it time for a change?
Bartoli A, Mascolo R, Tosti G, Luciano F, Caturano A; Scuola di metodologia della ricerca, SIMI. Bartoli A, et al. Among authors: caturano a. Intern Emerg Med. 2023 Aug;18(5):1569-1571. doi: 10.1007/s11739-023-03369-7. Epub 2023 Jul 25. Intern Emerg Med. 2023. PMID: 37491563 No abstract available.
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review.
Caturano A, D'Ardes D, Simeone PG, Lessiani G, Gregorio ND, Andreetto L, Grassi D, Serra C, Santilli F, Guagnano MT, Piscaglia F, Ferri C, Cipollone F, Boccatonda A. Caturano A, et al. J Clin Med. 2025 Aug 6;14(15):5549. doi: 10.3390/jcm14155549. J Clin Med. 2025. PMID: 40807170 Free PMC article. Review.
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes.
Salvatore T, Galiero R, Caturano A, Vetrano E, Rinaldi L, Coviello F, Di Martino A, Albanese G, Colantuoni S, Medicamento G, Marfella R, Sardu C, Sasso FC. Salvatore T, et al. Among authors: caturano a. Biomolecules. 2022 Jan 21;12(2):176. doi: 10.3390/biom12020176. Biomolecules. 2022. PMID: 35204677 Free PMC article. Review.
111 results